Susquehanna International Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-30,900
| Closed | -$6K | – | 11085 |
|
|
2018
Q1 | $6K | Sell |
30,900
-36,400
| -54% | -$33.6K | ﹤0.01% | 9197 |
|
|
2017
Q4 | $87K | Sell |
67,300
-15,500
| -19% | -$25.2K | ﹤0.01% | 8745 |
|
|
2017
Q3 | $176K | Buy |
82,800
+1,600
| +2% | +$3.9K | ﹤0.01% | 8109 |
|
|
2017
Q2 | $235K | Sell |
81,200
-35,700
| -31% | -$107K | ﹤0.01% | 8023 |
|
|
2017
Q1 | $402K | Buy |
116,900
+60,900
| +109% | +$240K | ﹤0.01% | 6878 |
|
|
2016
Q4 | $97K | Sell |
56,000
-85,800
| -61% | -$202K | ﹤0.01% | 9100 |
|
|
2016
Q3 | $471K | Buy |
141,800
+129,760
| +1,078% | +$490K | ﹤0.01% | 6163 |
|
|
2016
Q2 | $52K | Sell |
12,040
-5,810
| -33% | -$26.3K | ﹤0.01% | 8230 |
|
|
2016
Q1 | $100K | Buy |
17,850
+270
| +2% | +$3.51K | ﹤0.01% | 8432 |
|
|
2015
Q4 | $302K | Sell |
17,580
-3,490
| -17% | -$83.2K | ﹤0.01% | 7679 |
|
|
2015
Q3 | $445K | Buy |
21,070
+2,560
| +14% | +$87.7K | ﹤0.01% | 7343 |
|
|
2015
Q2 | $916K | Sell |
18,510
-47,310
| -72% | -$2.83M | ﹤0.01% | 6402 |
|
|
2015
Q1 | $5.15M | Sell |
65,820
-6,980
| -10% | -$433K | ﹤0.01% | 2698 |
|
|
2014
Q4 | $4.41M | Sell |
72,800
-44,120
| -38% | -$2.22M | ﹤0.01% | 3079 |
|
|
2014
Q3 | $4.98M | Buy |
116,920
+22,060
| +23% | +$1.18M | ﹤0.01% | 3024 |
|
|
2014
Q2 | $5.86M | Buy |
94,860
+8,610
| +10% | +$501K | ﹤0.01% | 2827 |
|
|
2014
Q1 | $5.61M | Buy |
86,250
+25,840
| +43% | +$1.75M | ﹤0.01% | 2731 |
|
|
2013
Q4 | $3.4M | Buy |
60,410
+2,760
| +5% | +$155K | ﹤0.01% | 3482 |
|
|
2013
Q3 | $3.54M | Sell |
57,650
-10,220
| -15% | -$692K | ﹤0.01% | 3228 |
|
|
2013
Q2 | $3.97M | Buy |
+67,870
| New | +$4.18M | ﹤0.01% | 2921 |
|
Other funds holding OREX
Susquehanna International Group's OREX Position: Q2 2018 in Review
Susquehanna International Group sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 88,896 shares — an estimated $18K sold.
Susquehanna International Group first reported a position in OREX in Q2 2013 and held it in 20 quarters. The position peaked at $7.16M in Q2 2014. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.
- Susquehanna International Group reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Susquehanna International Group sold 88,896 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $18K.
- Susquehanna International Group first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 20 quarters.
- Susquehanna International Group's Orexigen Therapeutics, Inc. position peaked at $7.16M in Q2 2014.
- 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.